Welcome to IVTEAM
Supporting clinical teams
IVUPDATE from IVTEAM
Portable ultrasound for peripheral intravenous access – Full Text
“The portable ultrasound system was associated with high first-attempt insertion success and high vascular visualization for peripheral intravenous access with no adverse events. The portable ultrasound system can be successfully used for bedside vascular access in a real-world environment” Kessel et al (2026).
Knotted guidewire during central venous catheterisation – Full Text
“Resuscitation is initiated with fluids and vasopressors, and a central venous catheter is placed. However, during the procedure, the guide experiences resistance and cannot be removed, becoming trapped” Valencia González et al (2026).
Impact of shortening of central venous catheter time on CLABSI rates – Full Text
“In conclusion, shortening the CVC dwell time in men by 2 or 3 days, corresponding to a CVC duration of 10-11 days, reduces the CRBSI rate in men and mitigates the higher risk, compared to women” Kriege et al (2026).
Off label use of PICCs as tunnelled non-cuffed centrally inserted central catheters – Full Text
“Off label use of PICCs as tnc-CICCs seems safe and effective. It provides an alternative to PICCs in oncology patients at high risk of thrombosis, even when placed by operators with low experience levels” Douchy et al (2026).
Prevention of arterial catheter-related bloodstream infections – Full Text
“Arterial catheters demonstrate an ongoing risk of contamination throughout their lifespan, from insertion to removal. A comprehensive prevention strategy should address the entire arterial catheter lifecycle and is most effective when implemented as a bundled approach” Donner et al (2026).
Saphenous vein for peripheral IV rescue access
“The distal medial thigh GSV can be reliably visualized using ultrasound across pediatric and adult populations, including those with prior difficult intravenous access” Saadi Neto et al (2026).
Resource-related factors associated with CLABSI
“This review identifies a critical gap in the literature: few studies examine CLABSI prevention from the perspective of healthcare providers in LMIC ICUs. Addressing the interconnected HCP, system, and resource-related barriers identified in this review is essential for developing effective, context-appropriate infection prevention strategies” Essani et al (2026).
Device-associated infection surveillance
“Among device-associated infections, the infection rate of VAP was the highest, showing a marked difference from CLABSI and CAUTI” Fujita et al (2026).
Ultrasound guidance for difficult intravenous access – Full Text
“The statistically significant improvements in DIVA identification and first-attempt success rates support integrating the ENA guidelines into rural emergency care” Hotchkiss et al (2026).
Vascular access nurses in industry survey
“Health care professionals generally perceive vascular access nurses employed in industry as valuable contributors to education and clinical practice when they possess appropriate clinical expertise” Kelly and Girgenti (2026).
Standards of care for peripheral intravenous catheters
“Our aim is to provide concise guidance that will enhance and standardize practices related to peripheral intravenous catheters (PIVC). By consolidating current standards of practice into a comprehensive document, our framework seeks to advance the quality of care and improve patient safety” Thompson et al (2026).
Difficult IV access position paper
“This position paper, endorsed by the Association for Vascular Access (AVA) outlines the scope and consequences of DIVA in hospitalized adult populations and proposes a comprehensive, evidence-based framework to support earlier recognition and more effective vascular access planning” Wuerz and Doellman (2026).
Device-related infections in Canadian acute care hospitals – Full Text
“The most commonly identified pathogens were coagulase-negative staphylococci (37%) in ICU-CLABSIs and Staphylococcus aureus (41%) in SSIs” Canadian Nosocomial Infection Surveillance Program1 (2026).
Catheter-related thrombosis in oncology patients with implanted ports
“For cancer patients who undergo ultrasound examinations for various reasons, the risk of CRT is relatively high. More attention should be paid to patients with breast cancer and with internal jugular vein implantation around 14 months after catheterization” Wu et al (2026)
Automating central line data capture and calculations
“Through real-time electronic data capture, a more efficient and sustainable process for maintaining accurate CL data and calculating A-CLABSI rates was developed” Martinez et al (2026).
Artificial intelligence in hemodialysis
“This narrative review synthesizes recent advances in AI applications for hemodialysis, examining their potential, technical approaches, and practical effectiveness in addressing current management challenges” Ren et al (2026).
Identification of risk factors for hospital-onset bacteremia – Full Text
“Most of the risk factors identified are well-recognized for Central Line-Associated Bloodstream Infection (CLABSI) and plausible contributors to HOB. Although not all HOB incidents are preventable, early identification of high-risk patients combined with risk-stratified targeted interventions can prevent cases and improve outcomes” Bludau et al (2026).
Safety and efficacy of PICC-ports in oncology patients
“PICC-port implementation achieved excellent safety outcomes comparable to international benchmarks, supporting its use as an alternative to chest ports in resource-constrained settings” Watts-Pajaro et al (2026).
Managing anxiety during preoperative peripheral IV insertion
“Current evidence for reducing anxiety during preoperative PIV insertion is limited and low in certainty. Lavender aromatherapy appears promising, but conclusions regarding its effectiveness should be considered preliminary” Majumdar et al (2026).
Midline catheter use in the intensive care unit
“Midline catheters (MC) are 10-20 cm intravenous (IV) lines inserted in the peripheral veins of the upper arm and utilized for patients who require longer term IV access, making them advantageous in the intensive care unit (ICU)” King et al (2026).
Intravenous iron administration and management of adverse events – Full Text
“Based on the available evidence, we provide practical recommendations for adverse events diagnosis, risk mitigation, patient counselling, and formulation selection to optimise the safe and effective use of i.v. iron for treatment and prevention of anaemia in routine clinical practice” Saal-Bauernschubert et al (2026).
Timing of the first IV dressing change after CVC insertion – Full Text
“To test whether a first dressing change at seven days is non-inferior to an additional change at 24 h, we conducted a multicenter randomized controlled non-inferiority trial in four Chinese pediatric ICUs (April 2021-December 2022)” Wang et al (2026).